Talquetamab with Iberdomide
A Phase Ib, Multi-center, Study of Talquetamab in Combination With Iberdomide and Dexamethasone for the Treatment of Relapsed or Refractory Multiple Myeloma
Arms / Cohorts
Experimental:Dose Escalation: Dose Level (DL) 1
Not yet accepting
Experimental:Dose Escalation: DL 2
Not yet accepting
Experimental:Dose Escalation: DL 3
Not yet accepting
Experimental:Dose Expansion
Not yet accepting
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print a patient-friendly report to share with your patient.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.